Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Novartis Raises Annual Sales and Profit Guidance on Strong Performance Standard Chartered Targets Efficiency with Corporate Functions Restructuring and Income Growth Goals Consumer Sentiment Plunges to Record Low in May Amid Iran Conflict and Oil Price Surge Niva Bupa Aims to Secure Top Two Retail Health Insurance Position Within Three Years Lack of Transparency in Estate Management Raises Red Flags for Beneficiaries ENVB Q4 2024 Earnings Deep EPS Miss and Continued PreRevenue Stage Pressure Consolidated Edison ED Q1 2026 Earnings Earnings Miss Estimates Stock Rises Slightly XRAY Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment CVKD Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline CompX International Inc CIX Q1 2026 Earnings Solid EPS Performance Amid Market Uncertainty Wing Yip Food Holdings Group WYHG Slips 49 as Support Levels Near Consolidation Phase EW Scripps SSP Slips 2 as Shares Test Key Support at 325 Autonomix Medical AMIX Shows Subtle Weakness at 042 as Support and Resistance Tighten Cameco CCJ Nears Support as Uranium Sector Faces Mixed Signals MAS Holdings and Hellmann Worldwide Logistics Launch New Fashion Hub in Sri Lanka Nvidias Earnings Reveal a 200 Billion Opportunity in Edge Computing Despite China Market Concession China Urges APEC Cooperation Amid Top Trade Ministers Absence at Key Meeting Jim Cramer Highlights Three Essential Assets for Retirement Amid Caution on ShortTerm Gains Cango Inc Q4 2025 Earnings Deep EPS Miss Triggers Stock Decline Stifel Q1 2026 Earnings Modest EPS Beat Amid Market Challenges Shares Edge Lower Kontoor Brands Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline Oxford Lane Capital Corp Preferred Stock Shares 600 Series 2029 OXLCO Q4 2025 Earnings EPS Misses Estimates Despite Solid Operating Results Serina Therapeutics Q1 2026 Earnings EPS Misses Estimates as Stock Climbs Despite Loss